Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Recruiting 4Completed 4Active not recruiting 3

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Conditions

Small Cell Lung Carcinoma 27Lymphoma, Large B-Cell, Diffuse 10Lung Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 6Hodgkin Disease 6Burkitt Lymphoma 6Neuroblastoma 5Medulloblastoma 5Neoplasms, Germ Cell and Embryonal 4Leukemia, Myeloid, Acute 4Small Cell Lung Cancer Extensive Stage 3Seminoma 3Retinoblastoma 3Recurrence 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma 3Carcinoma, Neuroendocrine 3Brain Neoplasms 3Wilms Tumor 2Urinary Bladder Neoplasms 2Teratoma 2Sarcoma, Ewing 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Neuroectodermal Tumors, Primitive 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2

Interventions

Etoposide 4Cisplatin 4lutetium Lu 177 dotatate 2fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Bleomycin 2repotrectinib 1pegfilgrastim 1etoposide phosphate 1copper dotatate CU-64 1Watchful Waiting 1Vorinostat 1Teniposide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Injections 1Immunotherapy 1Filgrastim 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Germ Cell and Embryonal × Etoposide × Clear all
NCT04804007 2026-05-08

Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

Indiana University

Phase 2 Recruiting
64 enrolled

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal

NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT06937866 2025-11-21

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

Indiana University

Phase 1/2 Recruiting
38 enrolled

Neoplasms, Germ Cell and Embryonal

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting
500 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡